Get the Stockscreener App
114.51
0.20%
-0.31
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Citigroup Inc stock is traded at $114.51, with a volume of 8.49M.
It is down -0.20% in the last 24 hours and down -4.84% over the past month.
Citigroup is a global financial-services company doing business in more than 160 countries and jurisdictions. Citigroup's operations are organized into five primary segments: services, markets, banking, US personal banking, and wealth management. The bank's primary services include cross-border banking needs for multinational corporates, investment banking and trading, and credit card services in the United States.
See More
Previous Close:
$114.82
Open:
$114.9
24h Volume:
8.49M
Relative Volume:
0.65
Market Cap:
$200.11B
Revenue:
$170.78B
Net Income/Loss:
$14.28B
P/E Ratio:
16.43
EPS:
6.9687
Net Cash Flow:
$25.64B
1W Performance:
+1.59%
1M Performance:
-4.84%
6M Performance:
+19.28%
1Y Performance:
+41.35%
1-Day Range:
$113.70
$115.97
1-Week Range:
$113.14
$116.64
52-Week Range:
$55.51
$124.17
Citigroup Inc Stock (C) Company Profile
Name
Citigroup Inc
Sector
Industry
Phone
(212) 559-1000
Address
388 GREENWICH STREET, NEW YORK, NY
Compare C with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
C
Citigroup Inc
|
114.51 | 200.65B | 170.78B | 14.28B | 25.64B | 6.9687 |
|
JPM
Jpmorgan Chase Co
|
299.11 | 811.66B | 279.88B | 56.78B | 45.88B | 20.01 |
|
BAC
Bank Of America Corp
|
52.05 | 375.19B | 194.71B | 30.63B | 42.62B | 3.833 |
|
HSBC
Hsbc Holdings Plc Adr
|
88.03 | 292.13B | 138.28B | 17.44B | 105.99B | 4.7081 |
|
WFC
Wells Fargo Co
|
88.72 | 272.31B | 123.81B | 21.36B | 35.82B | 6.2626 |
|
RY
Royal Bank Of Canada
|
168.51 | 234.28B | 97.16B | 14.56B | 14.01B | 10.06 |
Citigroup Inc Stock (C) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-25 | Upgrade | JP Morgan | Neutral → Overweight |
| May-15-25 | Initiated | TD Cowen | Hold |
| Jan-06-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-03-24 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Apr-04-24 | Reiterated | Evercore ISI | In-line |
| Mar-25-24 | Reiterated | Wells Fargo | Overweight |
| Mar-14-24 | Upgrade | Goldman | Neutral → Buy |
| Feb-14-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-30-24 | Upgrade | Morgan Stanley | Underweight → Overweight |
| Jan-10-24 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jan-09-24 | Upgrade | HSBC Securities | Hold → Buy |
| Jan-08-24 | Downgrade | Societe Generale | Hold → Sell |
| Jan-03-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-18-23 | Upgrade | Daiwa Securities | Neutral → Buy |
| Sep-07-23 | Initiated | HSBC Securities | Hold |
| Jul-18-23 | Upgrade | Odeon | Hold → Buy |
| Jul-10-23 | Downgrade | Societe Generale | Buy → Hold |
| Dec-08-22 | Initiated | Piper Sandler | Neutral |
| Oct-03-22 | Downgrade | Goldman | Buy → Neutral |
| Sep-06-22 | Downgrade | Odeon | Buy → Hold |
| May-27-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Mar-28-22 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Mar-07-22 | Downgrade | Jefferies | Buy → Hold |
| Mar-03-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Mar-03-22 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Dec-15-21 | Upgrade | Odeon | Hold → Buy |
| Dec-10-21 | Resumed | UBS | Neutral |
| Dec-06-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-07-21 | Resumed | Keefe Bruyette | Outperform |
| Jun-16-21 | Reiterated | Credit Suisse | Outperform |
| Apr-05-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Mar-29-21 | Downgrade | Edward Jones | Buy → Hold |
| Jan-21-21 | Downgrade | Berenberg | Buy → Hold |
| Jan-06-21 | Initiated | Daiwa Securities | Buy |
| Jan-04-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Nov-19-20 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Oct-15-20 | Downgrade | DZ Bank | Buy → Hold |
| Oct-08-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-18-20 | Downgrade | Odeon | Hold → Sell |
| Jul-17-20 | Downgrade | Odeon | Buy → Hold |
| Jul-08-20 | Initiated | Seaport Global Securities | Buy |
| Jul-07-20 | Upgrade | Societe Generale | Hold → Buy |
| Jun-09-20 | Downgrade | Standpoint Research | Buy → Hold |
| Jun-02-20 | Upgrade | Odeon | Hold → Buy |
| May-18-20 | Upgrade | Standpoint Research | Hold → Buy |
| Apr-20-20 | Upgrade | Argus | Hold → Buy |
| Apr-14-20 | Upgrade | Societe Generale | Sell → Hold |
| Apr-01-20 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Feb-03-20 | Downgrade | Odeon | Buy → Hold |
| Jan-09-20 | Initiated | DA Davidson | Buy |
| Jan-06-20 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-06-20 | Reiterated | Goldman | Buy |
| Jul-26-19 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| May-30-19 | Upgrade | Goldman | Neutral → Buy |
| Feb-22-19 | Upgrade | Jefferies | Hold → Buy |
View All
Citigroup Inc Stock (C) Latest News
Former Citi exec sues bank, alleging sexual harassment - Banking Dive
Why The Trade Desk Fell Yet Again Today - The Motley Fool
Citigroup names new leaders with corporate banking focus, memo shows By Reuters - Investing.com
Market Whales and Their Recent Bets on Citigroup Options - Benzinga
Citigroup names new leaders with corporate banking focus, memo shows - TradingView
TRV: Citigroup Maintains 'Sell' Rating, Raises Price Target to $315 | TRV Stock News - GuruFocus
USFD Stock Update: Citigroup Raises Price Target to $95 | USFD S - GuruFocus
Citigroup Maintains Street-High $1,500 Price Target on Eli Lilly Stock (LLY) - TipRanks
SSE.L Stock Today: January 27 Citi PT 2,036p Implies 13% Downside - Meyka
Citigroup Has Lowered Expectations for London Stock Exchange Group (LON:LSEG) Stock Price - MarketBeat
AstraZeneca (LON:AZN) Earns Buy Rating from Analysts at Citigroup - MarketBeat
GSK's (GSK) "Buy" Rating Reaffirmed at Citigroup - MarketBeat
Former Citi Executive Sues Bank Over Sexual Harassment - wealthmanagement.com
Citigroup CEO Jane Fraser says 175,000 employees are being trained to ‘reinvent themselves’ with AI before the tech changes their roles forever - Fortune
Citigroup Issues Pessimistic Forecast for AbbVie (NYSE:ABBV) Stock Price - MarketBeat
Citigroup Cuts Trade Desk (NASDAQ:TTD) Price Target to $38.00 - MarketBeat
Citigroup Maintains Neutral Rating on Biogen (BIIB), Raises Pric - GuruFocus
BMY: Citigroup Raises Price Target to $60, Maintains Neutral Rat - GuruFocus
Citigroup Raises Price Target for Gilead Sciences (GILD) to $156 - GuruFocus
Citigroup Maintains Neutral Rating on MRK, Raises Price Target t - GuruFocus
Citigroup’s Raghavan reshuffles corporate banking leadershipBloomberg - Investing.com
Citigroup Increases Gilead Sciences (NASDAQ:GILD) Price Target to $156.00 - MarketBeat
Citi Sees Silver Surging to $150 as China Buying Still Has Legs - Bloomberg
Merck & Co., Inc. (NYSE:MRK) Stock Price Expected to Rise, Citigroup Analyst Says - MarketBeat
Citigroup’s Raghavan Reshuffles Corporate Banking Leadership - Bloomberg
Northstar Advisory Group LLC Buys Shares of 20,915 Citigroup Inc. $C - MarketBeat
NWF Advisory Services Inc. Has $10.86 Million Stock Holdings in Citigroup Inc. $C - MarketBeat
Citi (C) Faces Legal Action Over Alleged Workplace Harassment - GuruFocus
Citigroup Harassment Lawsuit Puts Culture Governance And Execution Under Scrutiny - simplywall.st
Former Citi wealth executive sues bank; alleges harassment and biased HR probe - HR Katha
Citigroup wealth boss accused of ‘egregious’ harassment - Wealth Professional Canada
Citigroup Adjusts Price Target on Gilead Sciences to $156 From $140, Maintains Buy Rating - marketscreener.com
Citigroup Faces Lawsuit Over Sexual Harassment And Retaliation Claims - BW People
Citigroup Prepares New Round Of Senior-Level Layoffs - BW People
Citigroup (C) Stock; Gains Modestly Despite Legal Battle Over Executive Misconduct - CoinCentral
Citigroup analysts expect robust fiscal consolidation and ruling coalition stability in Romania this year - romania-insider.com
Citigroup Raises Price Target for Epiroc to SEK 280 (252), Reiterates BuyBN - marketscreener.com
Citigroup Initiates Coverage of Novo Nordisk with Neutral Rating and Price Target of 400 Danish KronerBN - marketscreener.com
Citigroup hit with lawsuit alleging ‘weaponized’ HR, hostile culture at wealth unit - InvestmentNews
Ex-Citi Exec Says Rampant Misogyny Was A 'Price Too Steep' - Law360
Ex-Citigroup executive sues bank claiming sexual harassment - Financial News London
Citigroup to cut managing directors and senior staff in March after January layoffsPeople Matters - People Matters - HR News
Citigroup stock edges higher as harassment lawsuit hits headlines ahead of Fed meeting - TechStock²
Former Citi Executive Sues Bank, Alleging Sexual Harassment - The Wall Street Journal
Citigroup sued by former executive who says it mishandled sexual harassment - Reuters
Citi ex-employee accuses top exec of ‘egregious’ sexual harassment, sues bank for forcing her out - New York Post
Ex-Citi Wealth Executive Sues Bank, Alleging Sexual Harassment - Bloomberg
Former Citigroup executive sues bank over handling of sexual harassment claims - Financial Times
Quilter (LON:QLT) Stock Price Expected to Rise, Citigroup Analyst Says - MarketBeat
Form FWP CITIGROUP INC Filed by: CITIGROUP INC - StreetInsider
Citigroup Raises Price Target for SSB to $120.00, Maintains Buy Rating | SSB Stock News - GuruFocus
Citigroup Inc Stock (C) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):